News

Filter

Current filters:

NovartisGenVec

GenVec extends research deal with Novartis

29-01-2012

US biopharma company GenVec (Nasdaq: GNVC) says that it has extended its research collaboration and license…

BiotechnologyGenVecNeurologicalNovartisPharmaceuticalResearch

Novartis in licensing deal with Cellectis; pays milestone to GenVec

07-12-2011

Paris, France-based Cellectis genome engineering specialist (Alternext: ALCLS) has signed a license agreement…

BiotechnologyCellectisGenVecLicensingNeurologicalNovartisPharmaceutical

GenVec signs new deal with Novartis on hearing disorder clinical trial material

09-08-2010

USA-based GenVec saw its share price rise 12% to $0.57 in pre-market trading last Friday, after the company…

GenVecLicensingNeurologicalNovartisPharmaceutical

Back to top